| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
1643 Stock Overview
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China.
Modern Chinese Medicine Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.43 |
| 52 Week High | HK$1.07 |
| 52 Week Low | HK$0.41 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -17.93% |
| 1 Year Change | -42.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -65.48% |
Recent News & Updates
Shareholder Returns
| 1643 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.2% | -7.0% | -3.4% |
| 1Y | -42.0% | -38.1% | -25.0% |
Return vs Industry: 1643 underperformed the Hong Kong Pharmaceuticals industry which returned -38.1% over the past year.
Return vs Market: 1643 underperformed the Hong Kong Market which returned -25% over the past year.
Price Volatility
| 1643 volatility | |
|---|---|
| 1643 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in HK Market | 12.7% |
| 10% least volatile stocks in HK Market | 3.1% |
Stable Share Price: 1643 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 1643's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 186 | Hongli Zhang | https://www.cdysjdyy.com |
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China.
Modern Chinese Medicine Group Co., Ltd. Fundamentals Summary
| 1643 fundamental statistics | |
|---|---|
| Market Cap | HK$261.00m |
| Earnings (TTM) | HK$96.44m |
| Revenue (TTM) | HK$423.96m |
2.7x
P/E Ratio0.6x
P/S RatioIs 1643 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1643 income statement (TTM) | |
|---|---|
| Revenue | CN¥384.96m |
| Cost of Revenue | CN¥218.76m |
| Gross Profit | CN¥166.21m |
| Other Expenses | CN¥78.63m |
| Earnings | CN¥87.57m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 43.17% |
| Net Profit Margin | 22.75% |
| Debt/Equity Ratio | 0% |
How did 1643 perform over the long term?
See historical performance and comparison